Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

NCT00199004 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Adult Acute Lymphocytic Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Dexamethasone / Prednisolone
DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Asparaginase
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: G-CSF
DRUG: Vindesine
DRUG: VP16
DRUG: Adriamycin
DRUG: Thioguanine
DRUG: VM26
DRUG: Rituximab
PROCEDURE: CNS irradiation
PROCEDURE: Mediastinal irradiation (if residual TU)
PROCEDURE: Stem cell transplantation

Sponsor

Johann Wolfgang Goethe University Hospital